Alambic Investment Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-22,026
Closed -$107K 41
2020
Q3
$107K Sell
22,026
-39,810
-64% -$151K 1.17% 30
2020
Q2
$119K Sell
61,836
-6,600
-10% -$13.5K 0.3% 126
2020
Q1
$129K Sell
68,436
-138,690
-67% -$434K 0.31% 112
2019
Q4
$930K Buy
207,126
+159,116
+331% +$989K 0.78% 25
2019
Q3
$399K Buy
48,010
+34,501
+255% +$377K 0.3% 129
2019
Q2
$169K Sell
13,509
-6,834
-34% -$96.6K 0.1% 248
2019
Q1
$310K Buy
+20,343
New +$337K 0.13% 224

Other funds holding STIM

Alambic Investment Management's STIM Position: Q4 2020 in Review

Alambic Investment Management sold out of Neuronetics (STIM) in Q4 2020, closing a stake of 22,026 shares — an estimated $107K sold.

Alambic Investment Management first reported a position in STIM in Q1 2019 and held it in 7 quarters. The position peaked at $930K in Q4 2019. 61 funds tracked by Wall St. Rank hold STIM as of Q4 2020.

  • Alambic Investment Management reported no remaining Neuronetics position as of Q4 2020 after selling out during the quarter.
  • Alambic Investment Management sold 22,026 Neuronetics shares in Q4 2020, an estimated $107K.
  • Alambic Investment Management first reported a position in Neuronetics in Q1 2019 and held it in 7 quarters.
  • Alambic Investment Management's Neuronetics position peaked at $930K in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Neuronetics as of Q4 2020.

Based on Alambic Investment Management's 13F filing for Q4 2020.